OmniStar Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.57M | Buy |
10,199
+947
| +10% | +$204K | 1.18% | 26 |
|
|
2026
Q1 | $2.01M | Buy |
9,252
+4,013
| +77% | +$890K | 1.04% | 30 |
|
|
2025
Q4 | $1.2M | Buy |
5,239
+536
| +11% | +$122K | 0.7% | 47 |
|
|
2025
Q3 | $1.09M | Sell |
4,703
-3,818
| -45% | -$777K | 0.66% | 49 |
|
|
2025
Q2 | $1.58M | Buy |
8,521
+1,195
| +16% | +$222K | 1.18% | 25 |
|
|
2025
Q1 | $1.54M | Sell |
7,326
-1,485
| -17% | -$289K | 1.22% | 22 |
|
|
2024
Q4 | $1.57M | Sell |
8,811
-1,108
| -11% | -$204K | 1.26% | 19 |
|
|
2024
Q3 | $1.97M | Sell |
9,919
-3,871
| -28% | -$722K | 1.47% | 11 |
|
|
2024
Q2 | $2.37M | Buy |
13,790
+516
| +4% | +$85.5K | 2.14% | 6 |
|
|
2024
Q1 | $2.42M | Buy |
13,274
+524
| +4% | +$90.3K | 2.21% | 6 |
|
|
2023
Q4 | $1.98M | Sell |
12,750
-958
| -7% | -$140K | 2.48% | 6 |
|
|
2023
Q3 | $2.05M | Hold |
13,708
| – | – | 2.44% | 8 |
|
|
2023
Q2 | $1.85M | Buy |
13,708
+24
| +0.2% | +$3.52K | 2.17% | 9 |
|
|
2023
Q1 | $2.18M | Sell |
13,684
-1,452
| -10% | -$222K | 2.77% | 7 |
|
|
2022
Q4 | $2.45M | Buy |
15,136
+421
| +3% | +$64.6K | 2.78% | 5 |
|
|
2022
Q3 | $1.98M | Buy |
14,715
+2,975
| +25% | +$427K | 2.35% | 6 |
|
|
2022
Q2 | $1.8M | Buy |
11,740
+479
| +4% | +$73.2K | 1.99% | 8 |
|
|
2022
Q1 | $1.82M | Sell |
11,261
-1,909
| -14% | -$277K | 1.81% | 11 |
|
|
2021
Q4 | $1.78M | Buy |
13,170
+300
| +2% | +$35.4K | 1.82% | 8 |
|
|
2021
Q3 | $1.39M | Buy |
+12,870
| New | +$1.47M | 1.64% | 11 |
|
|
2021
Q2 | – | Sell |
-12,825
| Closed | -$1.44M | – | 106 |
|
|
2021
Q1 | $1.39M | Sell |
12,825
-8,231
| -39% | -$880K | 1.77% | 11 |
|
|
2020
Q4 | $2.26M | Sell |
21,056
-5,615
| -21% | -$540K | 1.58% | 16 |
|
|
2020
Q3 | $2.34M | Buy |
26,671
+527
| +2% | +$49.6K | 1.76% | 14 |
|
|
2020
Q2 | $2.57M | Buy |
26,144
+1,813
| +7% | +$160K | 2.12% | 9 |
|
|
2020
Q1 | $1.85M | Sell |
24,331
-8,986
| -27% | -$765K | 1.82% | 14 |
|
|
2019
Q4 | $2.95M | Sell |
33,317
-339
| -1% | -$28.1K | 2.49% | 7 |
|
|
2019
Q3 | $2.55M | Buy |
33,656
+1,042
| +3% | +$71.4K | 2.23% | 8 |
|
|
2019
Q2 | $2.37M | Buy |
32,614
+246
| +0.8% | +$19.3K | 2.13% | 7 |
|
|
2019
Q1 | $2.61M | Buy |
32,368
+1,289
| +4% | +$105K | 2.29% | 7 |
|
|
2018
Q4 | $2.87M | Buy |
31,079
+5,535
| +22% | +$487K | 2.92% | 1 |
|
|
2018
Q3 | $2.42M | Buy |
25,544
+7,581
| +42% | +$719K | 1.84% | 9 |
|
|
2018
Q2 | $1.66M | Buy |
17,963
+277
| +2% | +$27.1K | 1.58% | 25 |
|
|
2018
Q1 | $1.67M | Sell |
17,686
-323
| -2% | -$35.5K | 1.6% | 24 |
|
|
2017
Q4 | $1.74M | Buy |
+18,009
| New | +$1.7M | 1.6% | 23 |
|
Other funds holding ABBV
ECSS
ATO
GAM
OmniStar Financial Group's ABBV Position: Q2 2026 in Review
OmniStar Financial Group increased its AbbVie (ABBV) stake by 10% in Q2 2026, buying an estimated $204K and bringing the position to 10,199 shares worth $2.57M. The position accounts for 1.18% of the portfolio, ranked #26.
OmniStar Financial Group first reported a position in ABBV in Q4 2017 and has held it in 34 quarters since. The position peaked at $2.95M in Q4 2019. 1,813 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- OmniStar Financial Group held 10,199 shares of AbbVie worth $2.57M as of Q2 2026.
- OmniStar Financial Group bought 947 AbbVie shares in Q2 2026, an estimated $204K.
- AbbVie made up 1.18% of OmniStar Financial Group's portfolio in Q2 2026, its #26 holding.
- OmniStar Financial Group first reported a position in AbbVie in Q4 2017 and has held it in 34 quarters since.
- OmniStar Financial Group's AbbVie position peaked at $2.95M in Q4 2019.
- 1,813 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on OmniStar Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.